DIN 02380927 — TEVA-ATOVAQUONE PROGUANIL 100 MG; 250 MG
TEVA-ATOVAQUONE PROGUANIL is a tablet of Atovaquone / Proguanil marketed by TEVA CANADA LIMITED. The full Atovaquone / Proguanil monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02380927
- Brand name
- TEVA-ATOVAQUONE PROGUANIL
- Active ingredient
- Atovaquone / Proguanil
- Strength
- 100 MG; 250 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- TEVA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Antimalarial agent (hydroxynaphthoquinone / biguanide combination)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Atovaquone / Proguanil products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02466783 | ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS | 100 MG; 250 MG | TABLET | GLENMARK PHARMACEUTICALS CANADA INC. | MARKETED |
| 02421429 | ATOVAQUONE PROGUANIL | 100 MG; 250 MG | TABLET | SANIS HEALTH INC | MARKETED |
| 02238151 | MALARONE | 100 MG; 250 MG | TABLET | GLAXOSMITHKLINE INC | MARKETED |
| 02264935 | MALARONE PEDIATRIC | 25.0 MG; 62.5 MG | TABLET | GLAXOSMITHKLINE INC | MARKETED |
| 02402165 | MYLAN-ATOVAQUONE/PROGUANIL | 100 MG; 250 MG | TABLET | MYLAN PHARMACEUTICALS ULC | MARKETED |